A computational method to estimate the relative biological effectiveness and tumor control probability for low-LET proton irradiations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41860858.
- Also identified by DOI 10.1371/journal.pone.0341352 and PMC identifier 13004361.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A constant relative biological effectiveness (RBE) value of 1.1 is used for proton therapy (PT) in many clinical treatment plans. However, several studies show that RBE varies with proton energy, linear energy transfer (LET), and oxygen concentration. This study presents a computational method based on the linear quadratic (LQ) and repair-misrepair-fixation (RMF) models to calculate tumor control probability (TCP) under varying oxygen conditions. We analyze the impact of hypoxia on the parameters of the LQ model, focusing on the ratio and RBE. The proposed method allows for TCP calculations across different oxygen concentrations and for various ion therapies, such as proton and carbon ion therapy. Our results show that increasing the LET from 1 to 12 keV/μm enhances TCP from 61% to 98% under aerobic conditions (21% O2), 45% to 98% under moderately hypoxic conditions (2% O2), and from 1% to 48% under severely hypoxic conditions (0.1% O2). These findings are compared with clinical trial data, demonstrating that hypoxia significantly affects TCP for low-LET radiations.
Medical subject headings
- Relative Biological Effectiveness
- Linear Energy Transfer
- Proton Therapy
- Neoplasms